| Pathway ID |
Gene ID |
Gene Symbol |
Gene Name |
| hsa04068 | 10000 | AKT3 | v-akt murine thymoma viral oncogene homolog 3 |
| hsa04068 | 10018 | BCL2L11 | BCL2-like 11 (apoptosis facilitator) |
| hsa04068 | 1017 | CDK2 | Cyclin-dependent kinase 2 |
| hsa04068 | 1026 | CDKN1A | Cyclin-dependent kinase inhibitor 1A (p21, Cip1) |
| hsa04068 | 1027 | CDKN1B | Cyclin-dependent kinase inhibitor 1B (p27, Kip1) |
| hsa04068 | 1030 | CDKN2B | cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4) |
| hsa04068 | 11337 | GABARAP | GABA(A) receptor-associated protein |
| hsa04068 | 1432 | MAPK14 | mitogen-activated protein kinase 14 |
| hsa04068 | 1647 | GADD45A | growth arrest and DNA-damage-inducible, alpha |
| hsa04068 | 1950 | EGF | epidermal growth factor |
| hsa04068 | 1956 | EGFR | Epidermal growth factor receptor (erythroblastic leukemia viral (v-erb-b) oncogene homolog, avian) |
| hsa04068 | 2033 | EP300 | E1A binding protein p300 |
| hsa04068 | 207 | AKT1 | v-akt murine thymoma viral oncogene homolog 1 |
| hsa04068 | 208 | AKT2 | V-akt murine thymoma viral oncogene homolog 2 |
| hsa04068 | 2308 | FOXO1 | forkhead box O1 |
| hsa04068 | 2309 | FOXO3 | Forkhead box O3 |
| hsa04068 | 23411 | SIRT1 | sirtuin 1 |
| hsa04068 | 23533 | PIK3R5 | phosphoinositide-3-kinase, regulatory subunit 5 |
| hsa04068 | 2885 | GRB2 | Growth factor receptor-bound protein 2 |
| hsa04068 | 3265 | HRAS | Harvey rat sarcoma viral oncogene homolog |
| hsa04068 | 3479 | IGF1 | Insulin-like growth factor 1 (somatomedin C) |
| hsa04068 | 3480 | IGF1R | Insulin-like growth factor 1 receptor |
| hsa04068 | 3551 | IKBKB | inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta |
| hsa04068 | 356 | FASLG | Fas ligand (TNF superfamily, member 6) |
| hsa04068 | 3569 | IL6 | interleukin 6 |
| hsa04068 | 3586 | IL10 | Interleukin 10 |
| hsa04068 | 3643 | INSR | insulin receptor |
| hsa04068 | 3667 | IRS1 | insulin receptor substrate 1 |
| hsa04068 | 369 | ARAF | A-Raf proto-oncogene, serine/threonine kinase |
| hsa04068 | 3845 | KRAS | V-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog |
| hsa04068 | 4087 | SMAD2 | SMAD family member 2 |
| hsa04068 | 4088 | SMAD3 | SMAD family member 3 |
| hsa04068 | 4089 | SMAD4 | SMAD family member 4 |
| hsa04068 | 4193 | MDM2 | MDM2 proto-oncogene, E3 ubiquitin protein ligase |
| hsa04068 | 4303 | FOXO4 | forkhead box O4 |
| hsa04068 | 4616 | GADD45B | growth arrest and DNA-damage-inducible, beta |
| hsa04068 | 472 | ATM | Ataxia telangiectasia mutated |
| hsa04068 | 4893 | NRAS | neuroblastoma RAS viral (v-ras) oncogene homolog |
| hsa04068 | 51422 | PRKAG2 | Protein kinase, AMP-activated, gamma 2 non-catalytic subunit |
| hsa04068 | 5170 | PDPK1 | 3-phosphoinositide dependent protein kinase-1 |
| hsa04068 | 51701 | NLK | nemo-like kinase |
| hsa04068 | 5290 | PIK3CA | phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha |
| hsa04068 | 5291 | PIK3CB | phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit beta |
| hsa04068 | 5293 | PIK3CD | phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit delta |
| hsa04068 | 5294 | PIK3CG | phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma |
| hsa04068 | 5295 | PIK3R1 | Phosphoinositide-3-kinase, regulatory subunit 1 (p85 alpha) |
| hsa04068 | 5296 | PIK3R2 | phosphoinositide-3-kinase, regulatory subunit 2 (beta) |
| hsa04068 | 5347 | PLK1 | polo-like kinase 1 |
| hsa04068 | 5562 | PRKAA1 | Protein kinase, AMP-activated, alpha 1 catalytic subunit |
| hsa04068 | 5563 | PRKAA2 | protein kinase, AMP-activated, alpha 2 catalytic subunit |
| hsa04068 | 5594 | MAPK1 | mitogen-activated protein kinase 1 |
| hsa04068 | 5595 | MAPK3 | mitogen-activated protein kinase 3 |
| hsa04068 | 5599 | MAPK8 | mitogen-activated protein kinase 8 |
| hsa04068 | 5600 | MAPK11 | mitogen-activated protein kinase 11 |
| hsa04068 | 5601 | MAPK9 | mitogen-activated protein kinase 9 |
| hsa04068 | 5604 | MAP2K1 | mitogen-activated protein kinase kinase 1 |
| hsa04068 | 5728 | PTEN | Phosphatase and tensin homolog (mutated in multiple advanced cancers 1) |
| hsa04068 | 5894 | RAF1 | V-raf-1 murine leukemia viral oncogene homolog 1 |
| hsa04068 | 595 | CCND1 | Cyclin D1 |
| hsa04068 | 604 | BCL6 | B-cell CLL/lymphoma 6 |
| hsa04068 | 6446 | SGK1 | serum/glucocorticoid regulated kinase 1 |
| hsa04068 | 6502 | SKP2 | S-phase kinase-associated protein 2, E3 ubiquitin protein ligase |
| hsa04068 | 664 | BNIP3 | BCL2/adenovirus E1B 19kDa interacting protein 3 |
| hsa04068 | 6648 | SOD2 | Superoxide dismutase 2, mitochondrial |
| hsa04068 | 6654 | SOS1 | son of sevenless homolog 1 (Drosophila) |
| hsa04068 | 673 | BRAF | B-Raf proto-oncogene, serine/threonine kinase |
| hsa04068 | 6774 | STAT3 | signal transducer and activator of transcription 3 (acute-phase response factor) |
| hsa04068 | 6794 | STK11 | Serine/threonine kinase 11 |
| hsa04068 | 7040 | TGFB1 | transforming growth factor, beta 1 |
| hsa04068 | 7042 | TGFB2 | transforming growth factor, beta 2 |
| hsa04068 | 7043 | TGFB3 | transforming growth factor, beta 3 |
| hsa04068 | 7046 | TGFBR1 | transforming growth factor, beta receptor 1 |
| hsa04068 | 7048 | TGFBR2 | Transforming growth factor, beta receptor II (70/80kDa) |
| hsa04068 | 7874 | USP7 | ubiquitin specific peptidase 7 (herpes virus-associated) |
| hsa04068 | 847 | CAT | Catalase |
| hsa04068 | 8503 | PIK3R3 | phosphoinositide-3-kinase, regulatory subunit 3 (gamma) |
| hsa04068 | 8660 | IRS2 | insulin receptor substrate 2 |
| hsa04068 | 891 | CCNB1 | cyclin B1 |
| hsa04068 | 894 | CCND2 | cyclin D2 |
| hsa04068 | 901 | CCNG2 | cyclin G2 |
| hsa04068 | 9133 | CCNB2 | cyclin B2 |
| hsa04068 | 9140 | ATG12 | autophagy related 12 |
| hsa04068 | 9455 | HOMER2 | homer scaffolding protein 2 |
